| Rank | Company | City | State | Country | Funding | Employees | Revenue | Predictive Score | Person Name | Title | Phone/Email |
|---|
| 1 | AandZ Pharmaceu... | Hauppauge | NY | USA | | 563 | $113.2M | 446 | Emma Li Xu | CEO & Chai... | |
| 2 | Madrigal Pharma | Philadelph... | PA | USA | $38.4M | 474 | $10.1M | 416 | Chris Dadas | VP, Field ... | |
| 3 | Xeris Pharmaceu... | Chicago | IL | USA | $155M | 391 | $35.3M | 355 | Kristin Marvin | General Co... | |
| 4 | Delcath Systems | New York C... | NY | USA | $138.4M | 74 | $7.5M | 274 | Carol Crooke | Assoc. VP ... | |
| 5 | ADARX | San Diego | CA | USA | | 62 | $12.5M | 266 | Zhen Li | CEO | |
| 6 | Apnimed | Boston | MA | | $208M | 50 | $5M | 226 | Larry Miller | CEO | |
| 7 | Montu | Melbourne | | Ger | | 318 | $63.9M | 224 | - | - | - |
| 8 | BigHat Bioscien... | Silicon Va... | CA | USA | | 109 | $21.9M | 219 | Mark DePristo | Founder an... | |
| 9 | Rénibus Therape... | Dallas | TX | | | 38 | $3.8M | 214 | Norma Schafer | VP Regulat... | |
| 10 | RareMed Solutio... | Pittsburgh | PA | USA | | 368 | $74M | 206 | Bill Valenta | VP - Techn... | |
| 11 | CymaBay Therape... | East Bay | CA | USA | $276M | 122 | $6.8M | 190 | Jason Speck | VP, Manufa... | |
| 12 | Tarsus Pharmace... | Orange Cou... | CA | USA | $60M | 263 | $56.7M | 187 | Mark Holdbrook | Sr VP, Cli... | |
| 13 | ORIC Pharmaceut... | San Franci... | CA | USA | $173M | 113 | $14.9M | 184 | Melissa Junttil... | VP | |
| 14 | LENZ Therapeuti... | San Diego | CA | | $50.4M | 28 | $2.8M | 183 | Ahmad Chaudhri | Head Comme... | |
| 15 | Rose's Super Di... | Hazlehurst | MS | USA | | 56 | $11.3M | 182 | - | - | - |
| 16 | Rgenta | Boston | MA | USA | | 39 | $7.8M | 181 | Simon Xi | Co-Founder... | |
| 17 | Cyclo Therapeut... | Gainesvill... | FL | | | 21 | $2.1M | 175 | - | - | - |
| 18 | Celltrion USA | New York C... | NJ | USA | | 39 | $7.8M | 170 | - | - | - |
| 19 | Synnovation The... | Philadelph... | DE | USA | | 38 | $7.6M | 164 | - | - | - |
| 20 | Engrail Therape... | San Diego | CA | USA | | 29 | $5.8M | 161 | Anil Vootkur | VP, Corpor... | |
| 21 | Civica Rx | Salt Lake ... | UT | USA | | 194 | $39M | 160 | Bouwien Smits | Site VP an... | |
| 22 | Novartis Pharma... | | | Switzerland | | 51 | $10.3M | 157 | - | - | - |
| 23 | August Bioservi... | Nashville | TN | USA | | 149 | $29.9M | 156 | Trent Cox | VP Manufac... | |
| 24 | Ratio Therapeut... | Boston | MA | USA | $90M | 38 | $3.8M | 155 | - | - | - |
| 25 | Phlow Corporati... | Richmond | VA | USA | $20M | 64 | $6.4M | 145 | Juan Piacquadio | Chief Info... | |
| 26 | Beckley Psytech | Oxford | | | | 75 | $15.1M | 143 | Berrak Selek | Commercial... | |
| 27 | Radionetics Onc... | San Diego | CA | | $137M | 26 | $2.6M | 143 | - | - | - |
| 28 | Osteal Therapeu... | Dallas | TX | | $60.8M | 26 | $2.6M | 140 | Todd Saunders | VP Marketi... | |
| 29 | Mirum Pharmaceu... | San Franci... | CA | USA | $120M | 308 | $86.7M | 139 | Andrew McKibben | VP | |
| 30 | Vigil Neuroscie... | Boston | MA | USA | $140M | 80 | $7.6M | 137 | Ali Toumadj | VP, Head M... | |
| 31 | Harpoon Therape... | San Franci... | CA | USA | $130M | 63 | $26.8M | 132 | Wendy Chang | Sr VP, Hum... | |
| 32 | CorMedix | Bedminster | NJ | USA | $11.5M | 84 | $7.5M | 132 | Antony Pfaffle | Head Patie... | |
| 33 | Catalyst Pharma... | Miami | FL | USA | | 173 | $34.8M | 128 | Ismaris Bouchar... | VP, Financ... | |
| 34 | Rising Pharma H... | East Bruns... | NJ | USA | | 264 | $53.1M | 124 | Ira Baeringer | COO | |
| 35 | TFF Pharmaceuti... | Austin | TX | USA | $22.2M | 40 | $3.2M | 123 | Kirk Coleman | CFO | |
| 36 | Arrowhead Pharm... | Los Angele... | CA | Indonesia | $449.9M | 506 | $138.3M | 120 | Tao Pei | Group VP, ... | |
| 37 | Umoja Biopharma | Seattle | WA | USA | $263M | 240 | $48.2M | 117 | Ryan Crisman | Co-founder... | |
| 38 | SpyGlass Pharma | Orange Cou... | CA | | $90M | 33 | $3.3M | 116 | - | - | - |
| 39 | Pace Life Scien... | Minneapoli... | MN | USA | | 385 | $77.4M | 108 | Steve Vanderboo... | Founder, C... | |
| 40 | PLUS THERAPEUTI... | Austin | TX | USA | | 24 | $2.4M | 108 | - | - | - |
| 41 | WEP Clinical | Raleigh Du... | NC | USA | | 183 | $36.8M | 106 | Matt Comstock | VP and Glo... | |
| 42 | Niowave | Lansing | MI | USA | | 117 | $23.5M | 106 | - | - | - |
| 43 | Acumen Pharmace... | Charlottes... | VA | USA | | 73 | $3.8M | 104 | Stephen Reynold... | Associate ... | |
| 44 | PharmaCord | Louisville | KY | USA | | 597 | $120M | 103 | Nitin Sahney | Founder & ... | |
| 45 | PurpleLab | Philadelph... | PA | USA | | 92 | $18.5M | 103 | Eugene Fievitz | SVP, Healt... | |
| 46 | Theralase Techn... | Toronto | ON | CAN | | 29 | $2.9M | 100 | - | - | - |
| 47 | Curexa | Galloway | NJ | USA | | 121 | $24.3M | 98 | Robert Cimorell... | SVP Regula... | |
| 48 | Northwind Pharm... | Indianapol... | IN | USA | | 63 | $12.7M | 94 | Phillip Berry | Founder an... | |
| 49 | Lyra Therapeuti... | Boston | MA | USA | | 117 | $23.5M | 94 | Marina Mihova | Associate ... | |
| 50 | Afton Scientifi... | Charlottes... | VA | | | 59 | $11.9M | 94 | - | - | - |
| 51 | Nutra-Med Packa... | Whippany | NJ | USA | | 104 | $20.9M | 93 | Kathleen Tirch | VP Quality... | |
| 52 | Apollo Care | Chicago | IL | USA | | 36 | $7.2M | 92 | - | - | - |
| 53 | Fagron Sterile ... | Wichita | KS | USA | | 236 | $47.4M | 91 | Joe Pudlo | Director, ... | |
| 54 | Meitheal Pharma... | Chicago | IL | USA | | 102 | $20.5M | 89 | Jennifer Mokos | EVP Operat... | |
| 55 | The Ritedose Co... | Columbia | SC | USA | | 345 | $69.3M | 89 | Duane Miskelly | CFO | |
| 56 | Aqemia | Paris | | France | | 70 | $14.1M | 88 | Maximilien Leve... | CEO and co... | |
| 57 | Rutgers Pharmac... | Piscataway... | NJ | | | 50 | $10.1M | 87 | - | - | - |
| 58 | Inato | Paris | | | $35.5M | 85 | $17.1M | 87 | Kourosh Davarpa... | Co-founder... | |
| 59 | Catalyst Clinic... | Raleigh Du... | NC | USA | | 669 | $134.5M | 86 | Nick Dyer | CEO | |
| 60 | STAQ PHARMA | Denver | CO | USA | | 87 | $17.5M | 86 | Joe Bagan | CEO | |
| 61 | Ephicacy | Iselin | NJ | USA | | 519 | $104.3M | 86 | Ashwini Shah-Ka... | Head Human... | |
| 62 | SSI Strategy | Parsippany | NJ | USA | | 116 | $23.3M | 86 | Jessica Pry | VP | |
| 63 | Novalix | ILLKIRCH | | | | 459 | $92.3M | 86 | - | - | - |